Analysis of Rotterdam Study cohorts confirms a previously identified <i>RIPOR2</i> in-frame deletion as a prevalent genetic factor in phenotypically variable adult-onset hearing loss (DFNA21) in the Netherlands.

Velde, Hedwig M; Homans, Nienke C; Goedegebure, André; Lanting, Cornelis P; Pennings, Ronald J E; Kremer, Hannie

Analysis of Rotterdam Study cohorts confirms a previously identified RIPOR2 in-frame deletion as a prevalent genetic factor in phenotypically variable adult-onset hearing loss (DFNA21) in the Netherlands.

Velde, Hedwig M; Homans, Nienke C; Goedegebure, André; Lanting, Cornelis P; Pennings, Ronald J E; Kremer, Hannie.

Afiliação

Velde HM; Department of Otorhinolaryngology, Radboudumc, Nijmegen, The Netherlands.
Homans NC; Donders Institute for Brain Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Goedegebure A; Department of Otorhinolaryngology Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Lanting CP; Department of Otorhinolaryngology Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Pennings RJE; Department of Otorhinolaryngology, Radboudumc, Nijmegen, The Netherlands.
Kremer H; Donders Institute for Brain Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

J Med Genet ; 60(11): 1061-1066, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37164627